logo
Select company
Select metric
-80.73%Return on Equity
VS
Market
14
Sector
37
Industry
26
History
48
$ 11.72Close
$ 2.43 - $ 11.92 52-Week Range
Ticker Information

Ticker

XGN

Company Name

EXAGEN INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

EXAGEN INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XGN - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 21.03M$ -16.98M-80.73%
3/31/2025$ 6.4M$ -15.51M-242.18%
12/31/2024$ 9.54M$ -15.12M-158.44%
9/30/2024$ 12.87M$ -16.93M-131.54%
6/30/2024$ 17.59M$ -17.31M-98.46%
3/31/2024$ 19.99M$ -19.36M-96.85%
12/31/2023$ 22.69M$ -23.69M-104.38%
9/30/2023$ 27.5M$ -32.47M-118.06%
6/30/2023$ 31.9M$ -35.15M-110.18%
3/31/2023$ 35.94M$ -44.8M-124.67%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EXAGEN INC's latest trailing twelve months (TTM) ROE stands at -37.42%.
  • Over the past 5 years, EXAGEN INC's average ROE has been -86.04%.
  • The median ROE for EXAGEN INC during this period was -88.79%
  • EXAGEN INC reached its highest ROE over the past 5 years at -17.08%.
  • The lowest ROE recorded by EXAGEN INC in the same timeframe -242.18%

EXAGEN INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
CVRX : CVRX INC -90.19%ELMD : ELECTROMED INC 17.44%DERM : JOURNEY MEDICAL CORP -45.4%LNSR : LENSAR INC -ACRS : ACLARIS THERAPEUTICS INC -102.21%ENTA : ENANTA PHARMACEUTICALS INC -116.06%MASS : 908 DEVICES INC -12.39%THTX : THERATECHNOLOGIES INC -SGHT : SIGHT SCIENCES INC -70%PDEX : PRO DEX INC 24.51%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for EXAGEN INC is calculated as follows: Net Inc. Cmn. [ $ -16.64M ] / Equity [ $ 44.47M ]
(=) ROE [ -37.42% ]

XGN - Return on Equity, Last 5 years

-242.18%

Minimum

Mar 31, 2025

-17.08%

Maximum

Mar 31, 2021

-86.04%

Average

-88.79%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.68%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.68%